Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Actigraphy Improvement With Voxelotor (ActIVe) Study

ClinicalTrials.gov ID: NCT04400487

Public ClinicalTrials.gov record NCT04400487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 5:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Multicenter, Open-label Study to Evaluate the Treatment Effect of Voxelotor on Physical Activity in Adolescents and Adults With Sickle Cell Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study to evaluate the effect of voxelotor on daily physical activity and sleep quality, as measured by a wrist-worn device in participants with sickle cell disease (SCD) and chronic moderate anemia.

Study identification

NCT ID
NCT04400487
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
25 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 21, 2020 (Actual)
Primary completion
Sep 8, 2022 (Actual)
Completion
Sep 13, 2022 (Actual)
Last update posted
Nov 21, 2023

2020 – 2022

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
UConn Health Farmington Connecticut 06030 —
Children's Healthcare of Atlanta Atlanta Georgia 30342 —
Children's Hospital of Michigan Detroit Michigan 48201 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
The Children's Hospital at Montefiore The Bronx New York 10476 —
Duke Department of Pediatrics Durham North Carolina 27710 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
The University of Texas Health Science Center at Houston Houston Texas 77030 —
VCU Health Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04400487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 21, 2023 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04400487 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →